Follow the Bliss GVS Pharma Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Bliss GVS Pharma Limited has logged 32 reports. Market capitalisation: €45bn. The latest transaction was filed on 19 December 2025 (Purchase). Among the most active insiders: Mr. Gagan Harsh Sharma. The full history is openly available.
32
Insider Decl.
0
Thresholds
€5m
31 ops.
Buy Volume
€2m
1 ops.
Sell Volume
19Σ signal
Buys €5m€2m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7,188 of 25,837 companies
62.7
score / 100
Value
50
Quality
76
FCF yld1.8%
Earn yld2.9%
EV/EBITDA·
ROE·
Gross mgn54%
Net mgn14%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.